{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Dose+Drug+A&page=15", "query": { "intervention": "Low Dose Drug A", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 1207, "total_pages": 121, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Dose+Drug+A&page=16&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Dose+Drug+A&page=14&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T12:16:26.606Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01771809", "title": "Long-Term Safety Of PF-00547659 In Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "75mg SHP647 (PF-00547659)", "type": "DRUG" }, { "name": "225mg SHP647 (PF-00547659)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "66 Years", "sex": "ALL", "summary": "18 Years to 66 Years" }, "enrollment_count": 330, "start_date": "2013-03-18", "completion_date": "2017-12-13", "has_results": true, "last_update_posted_date": "2021-06-03", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 29, "location_summary": "Scottsdale, Arizona • La Jolla, California • Orange, California + 26 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Thornton", "state": "Colorado" }, { "city": "Hamden", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01771809" }, { "nct_id": "NCT04556773", "title": "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Breast Cancer" ], "interventions": [ { "name": "Trastuzumab deruxtecan", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Capivasertib", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 138, "start_date": "2020-12-17", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 9, "location_summary": "Commack, New York • Harrison, New York • New York, New York + 5 more", "locations": [ { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Uniondale", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04556773" }, { "nct_id": "NCT03248479", "title": "Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hematological Malignancies" ], "interventions": [ { "name": "Magrolimab", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 258, "start_date": "2017-09-08", "completion_date": "2023-09-05", "has_results": true, "last_update_posted_date": "2025-01-17", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 26, "location_summary": "Duarte, California • La Jolla, California • Los Angeles, California + 20 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03248479" }, { "nct_id": "NCT01263054", "title": "Safety and Efficacy of the TransDiscal System Versus Medical Management in Treating Chronic Discogenic Low Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Back Pain" ], "interventions": [ { "name": "TransDiscal System", "type": "DEVICE" }, { "name": "Medical Management", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Halyard Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 67, "start_date": "2010-12", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2018-07-10", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 9, "location_summary": "Washington D.C., District of Columbia • Orlando, Florida • Bloomington, Illinois + 6 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Orlando", "state": "Florida" }, { "city": "Bloomington", "state": "Illinois" }, { "city": "Silver Spring", "state": "Maryland" }, { "city": "Linwood", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01263054" }, { "nct_id": "NCT00442169", "title": "Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "West Nile Fever" ], "interventions": [ { "name": "ChimeriVax-WN02 Low Dose", "type": "BIOLOGICAL" }, { "name": "ChimeriVax-WN02 Medium Dose", "type": "BIOLOGICAL" }, { "name": "ChimeriVax-WN02 High Dose", "type": "BIOLOGICAL" }, { "name": "0.9% Saline solution", "type": "BIOLOGICAL" }, { "name": "0.9 % NaCl solution", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 208, "start_date": "2005-12", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Idaho Falls, Idaho • Lenexa, Kansas + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00442169" }, { "nct_id": "NCT02299505", "title": "Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "ceritinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 306, "start_date": "2015-04-09", "completion_date": "2020-03-06", "has_results": false, "last_update_posted_date": "2022-02-09", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 7, "location_summary": "Fayetteville, Arkansas • Loma Linda, California • Indianapolis, Indiana + 4 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Rockville", "state": "Maryland" }, { "city": "Belleville", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02299505" }, { "nct_id": "NCT06052956", "title": "Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Abscess" ], "interventions": [ { "name": "Methylene Blue", "type": "DRUG" }, { "name": "Lipid Emulsion", "type": "DRUG" }, { "name": "Insertion of optical fiber", "type": "DEVICE" }, { "name": "Laser Illumination (pre-defined dose)", "type": "DEVICE" }, { "name": "Optical Spectroscopy Measurement", "type": "DEVICE" }, { "name": "Laser Illumination (patient-specific dose)", "type": "DEVICE" }, { "name": "Standard of care abscess drainage", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "DEVICE", "PROCEDURE" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2027-07-15", "completion_date": "2032-06-30", "has_results": false, "last_update_posted_date": "2026-11-06", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 2, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06052956" }, { "nct_id": "NCT01499888", "title": "Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "Allogeneic Non-Myeloablative Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Alemtuzumab", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "University of Illinois Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "16 Years to 60 Years" }, "enrollment_count": 45, "start_date": "2011-11-11", "completion_date": "2029-10", "has_results": false, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01499888" }, { "nct_id": "NCT00061893", "title": "Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "celecoxib", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "vinblastine sulfate", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" }, { "name": "MESNA", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "50 Years", "sex": "ALL", "summary": "Up to 50 Years" }, "enrollment_count": 38, "start_date": "2004-04", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00061893" }, { "nct_id": "NCT03588884", "title": "Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Secondary Hyperparathyroidism Due to Renal Causes", "Vitamin D Insufficiency", "CKD Stage 3", "CKD Stage 4" ], "interventions": [ { "name": "Calcifediol Oral Capsule", "type": "DRUG" }, { "name": "Calcifediol Oral Product", "type": "DRUG" }, { "name": "Cholecalciferol", "type": "DRUG" }, { "name": "Paricalcitol Oral Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OPKO Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2018-06-08", "completion_date": "2020-04-24", "has_results": true, "last_update_posted_date": "2022-12-09", "last_synced_at": "2026-11-15T12:16:26.606Z", "location_count": 3, "location_summary": "Garden Grove, California • Chicago, Illinois • West Bend, Wisconsin", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03588884" } ] }